Medicine

Gérard Reach

2026.3.1DIABETES & METABOLISM

DOI: 10.1016/j.diabet.2026.101745

Abstract

This editorial argues that technological innovation in diabetes, particularly continuous glucose monitoring and hybrid closed-loop systems, must be integrated into a humane medicine centred on both metrics and persons. It was written under the pressure of observing that diabetes distress persists in a substantial proportion of patients who benefit from the most advanced technologies, including hybrid closed‑loop systems. The author describes each patient's situation as a "mental puzzle" of beliefs, emotions and social constraints and highlights the biographical ruptures caused by disease and technology. The clinical encounter has a double object-the disease and the person-held together through clinical conversation that translates innovation into livable choices for each individual. It is where technicality meets humanity.

Citation format

REACH, Gérard. Towards humane diabetes care in the era of technological innovation. DIABETES & METABOLISM, 2026, 52(2): 101745.